Trademark Overview
On Tuesday, May 5, 2026, a trademark application was filed for OPROVDA with the United States Patent and Trademark Office. The USPTO has given the OPROVDA trademark a serial number of 99804604. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, May 5, 2026. This trademark is owned by Pfizer Inc.. The OPROVDA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorder; Pharmaceutical preparations for the treatment of the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceuticals, namely, anti-infectives; Medicated dermatological preparations and substances; Smoking cessation preparations; Vaccines for human use; Pharmaceutical preparations for the treatment of for the treatment of sickle cell disease; Pharmaceutical preparations for the treatment of hypoxic and hypoxemic conditions
